Vanguard Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.71M Buy
2025
Q1
$4.45M Sell
2024
Q4
$6.25M Sell
2024
Q3
$5.94M Buy
2024
Q2
$4.04M Sell
2024
Q1
$4.64M Buy
2023
Q4
$4.45M Buy
2023
Q3
$775K Buy